{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:53:40Z","timestamp":1792641220931,"version":"4.5.0"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2017,5,30]],"date-time":"2017-05-30T00:00:00Z","timestamp":1496102400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s40620-017-0412-z","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T23:32:18Z","timestamp":1496100738000},"page":"197-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":94,"title":["ANCA-associated vasculitis with renal involvement"],"prefix":"10.1093","volume":"31","author":[{"given":"Valentina","family":"Binda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Moroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,5,30]]},"reference":[{"key":"412_CR1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthr Rheum 37:187\u2013192","journal-title":"Arthr Rheum"},{"issue":"1","key":"412_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC et al (2013) 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthr Rheum 65(1):1\u201311","journal-title":"Arthr Rheum"},{"issue":"9","key":"412_CR3","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1136\/annrheumdis-2015-207601","volume":"75","author":"C Rahmattulla","year":"2016","unstructured":"Rahmattulla C et al (2016) Genetic variants in ANCA-associated vasculitis: a meta-analysis. Ann Rheum 75(9):1687\u201392","journal-title":"Ann Rheum"},{"issue":"4","key":"412_CR4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s40620-016-0303-8","volume":"29","author":"F Maritati","year":"2016","unstructured":"Maritati F et al (2016) Kidney involvement in medium- and large-vessel vasculitis. J Nephrol 29(4):495\u2013505","journal-title":"J Nephrol"},{"issue":"Suppl 1","key":"412_CR5","first-page":"1422","volume":"30","author":"RA Watts","year":"2015","unstructured":"Watts RA et al (2015) Classification, epidemiology and clinical subgrouping of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Nephrol Dial Transplant 30(Suppl 1):14\u201322","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"412_CR6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/art.20077","volume":"51","author":"A Mahr","year":"2004","unstructured":"Mahr A et al (2004) Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener\u2019s granulomatosis, and Churg\u2013Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthr Rheum 51(1):92\u20139","journal-title":"Arthr Rheum"},{"issue":"4","key":"412_CR7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1445-5994.2006.01297.x","volume":"37","author":"JL O\u2019Donnell","year":"2007","unstructured":"O\u2019Donnell JL et al (2007) Wegener\u2019s granulomatosis in New Zealand: evidence for a latitude-dependent incidence gradient. Intern Med J 37(4):242\u2013246","journal-title":"Intern Med J"},{"issue":"4","key":"412_CR8","first-page":"284","volume":"24","author":"M Andrews","year":"1990","unstructured":"Andrews M et al (1990) Systemic vasculitis in the 1980s\u2014is there an increasing incidence of Wegener\u2019s granulomatosis and microscopic polyarteritis? J R Coll Physicians Lond 24(4):284\u2013288","journal-title":"J R Coll Physicians Lond"},{"issue":"10","key":"412_CR9","first-page":"2060","volume":"33","author":"A Knight","year":"2006","unstructured":"Knight A et al (2006) Increasing incidence of Wegener\u2019s granulomatosis in Sweden, 1975\u20132001. J Rheumatol 33(10):2060\u20132063","journal-title":"J Rheumatol"},{"issue":"4","key":"412_CR10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2012.08.008","volume":"12","author":"A Radice","year":"2013","unstructured":"Radice A et al (2013) Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev 12(4):487\u2013495","journal-title":"Autoimmun Rev"},{"issue":"6","key":"412_CR11","first-page":"707","volume":"18","author":"A Radice","year":"2000","unstructured":"Radice A et al (2000) Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Clin Exp Rheumatol 18(6):707\u2013712","journal-title":"Clin Exp Rheumatol"},{"key":"412_CR12","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1365-2249.2007.03453.x","volume":"150","author":"MV Taylor","year":"2007","unstructured":"Taylor MV et al (2007) Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Clin Exp Immunol 150:42\u201348","journal-title":"Clin Exp Immunol"},{"key":"412_CR13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/s10165-010-0356-9","volume":"21","author":"I Kida","year":"2011","unstructured":"Kida I et al (2011) Antineutrophil cytoplasmic antibodies against myeloperoxidase, proteinase 3, elastase, cathepsin G and lactoferrin in Japanese patients with rheumatoid arthritis. Mod Rheumatol 21:43\u201350","journal-title":"Mod Rheumatol"},{"key":"412_CR14","first-page":"1248","volume":"30","author":"D Khanna","year":"2003","unstructured":"Khanna D et al (2003) Bactericidal\/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30:1248\u20131252","journal-title":"J Rheumatol"},{"issue":"10","key":"412_CR15","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"R Kain","year":"2008","unstructured":"Kain R et al (2008) Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 14(10):1088\u20131096","journal-title":"Nat Med"},{"issue":"3","key":"412_CR16","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2011090920","volume":"23","author":"R Kain","year":"2012","unstructured":"Kain R et al (2012) High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis. J Am Soc Nephrol 23(3):556\u2013566","journal-title":"J Am Soc Nephrol"},{"key":"412_CR17","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10067-015-3086-8","volume":"35","author":"S Shah","year":"2016","unstructured":"Shah S et al (2016) A historical study of American patients with anti-neutrophil cytoplasmic antibody negative pauci-immune glomerulonephritis. Clin Rheumatol 35:953\u2013960","journal-title":"Clin Rheumatol"},{"issue":"3","key":"412_CR18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/ckj\/sfv020","volume":"8","author":"OO Rowaiye","year":"2015","unstructured":"Rowaiye OO et al (2015) The kidneys and ANCA-associated vasculitis: from pathogenesis to diagnosis. Clin Kidney J 8(3):343\u2013350","journal-title":"Clin Kidney J"},{"issue":"8","key":"412_CR19","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrrheum.2014.103","volume":"10","author":"JC Jennette","year":"2014","unstructured":"Jennette JC, Falk RJ (2014) Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol 10(8):463\u2013473","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"412_CR20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","volume":"1","author":"H Xiao","year":"2015","unstructured":"Xiao H et al (2015) Overview of the pathogenesis of ANCA-associated vasculitis. Kidney Dis 1(4):205\u201315","journal-title":"Kidney Dis"},{"issue":"2","key":"412_CR21","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/ar392","volume":"4","author":"ER Popa","year":"2002","unstructured":"Popa ER et al (2002) Staphylococcus aureus and Wegener\u2019s granulomatosis. Arthr Res 4(2):77\u201379","journal-title":"Arthr Res"},{"issue":"1","key":"412_CR22","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/BOR.0b013e3283323538","volume":"22","author":"E Csernok","year":"2010","unstructured":"Csernok E et al (2010) Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis. Curr Opin Rheumatol 22(1):43\u201348","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"412_CR23","doi-asserted-by":"crossref","first-page":"643.e9643.14","DOI":"10.1016\/j.amjmed.2006.08.016","volume":"120","author":"JD Finkielman","year":"2007","unstructured":"Finkielman JD et al (2007) ANCA are detectable in nearly all patients with active severe Wegener\u2019s granulomatosis. Am J Med 120(7):643.e9\u2013643.14","journal-title":"Am J Med"},{"issue":"10","key":"412_CR24","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nrrheum.2016.123","volume":"12","author":"D Cornec","year":"2016","unstructured":"Cornec D et al (2016) ANCA-associated vasculitis\u2014clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 12(10):570\u2013579","journal-title":"Nat Rev Rheumatol"},{"issue":"12","key":"412_CR25","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"JH Schirmer","year":"2016","unstructured":"Schirmer JH et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German Vasculitis Referral Center. Arthr Rheumatol 68(12):2953\u20132963","journal-title":"Arthr Rheumatol"},{"key":"412_CR26","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"PA Lyons","year":"2012","unstructured":"Lyons PA et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214\u2013223","journal-title":"N Engl J Med"},{"key":"412_CR27","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1002\/art.34496","volume":"64","author":"SA Chung","year":"2012","unstructured":"Chung SA et al (2012) Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener\u2019s) reveals shared susceptibility loci with rheumatoid arthritis. Arthr Rheum 64:3463\u20133471","journal-title":"Arthr Rheum"},{"key":"412_CR28","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1002\/art.38036","volume":"65","author":"G Xie","year":"2013","unstructured":"Xie G et al (2013) Association of granulomatosis with polyangiitis (Wegener\u2019s) with HLA-DPB1*04 and SEMA6A gene variants: evidence from genome-wide analysis. Arthr Rheum 65:2457\u20132468","journal-title":"Arthr Rheum"},{"key":"412_CR29","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.39620","volume":"68","author":"M Hilhorst","year":"2016","unstructured":"Hilhorst M et al (2016) HLA-DPB1 as a risk factor for relapse in antineutrophil cytoplasmic antibody-associated vasculitis: a cohort study. Arthr Rheumatol 68:1721\u20131730","journal-title":"Arthr Rheumatol"},{"issue":"3","key":"412_CR30","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.berh.2009.03.001","volume":"23","author":"D Jayne","year":"2009","unstructured":"Jayne D (2009) The diagnosis of vasculitis. Best Pract Res Clin Rheumatol 23(3):445\u2013453","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"412_CR31","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.autrev.2012.08.006","volume":"12","author":"RA Sinico","year":"2013","unstructured":"Sinico RA et al (2013) Renal involvement in anti-neutrophil cytoplasmic autoantibody associated vasculitis. Autoimmun Rev 12(4):477\u2013482","journal-title":"Autoimmun Rev"},{"key":"412_CR32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2014.01.023","volume":"48\u201349","author":"CG Kallenberg","year":"2014","unstructured":"Kallenberg CG (2014) The diagnosis and classification of microscopic polyangiitis. J Autoimmun 48\u201349:90\u201393","journal-title":"J Autoimmun"},{"key":"412_CR33","first-page":"625","volume-title":"Heptinstall\u2019s pathology of the kidney","year":"1998","unstructured":"Jennette JC, Olson JL, Schwartz MM, Silva FG (eds) (1998) Heptinstall\u2019s pathology of the kidney, 5th edn. Lippincott-Raven publishers, Philadelphia, pp\u00a0625\u2013656","edition":"5"},{"issue":"4","key":"412_CR34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.autrev.2012.08.003","volume":"12","author":"RA Sinico","year":"2013","unstructured":"Sinico RA, Meroni P (2013) The kaleidoscopic manifestations of systemic vasculitis. Autoimmun Rev 12(4):459\u2013462","journal-title":"Autoimmun Rev"},{"issue":"7","key":"412_CR35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.autrev.2010.02.006","volume":"9","author":"AM Schilder","year":"2010","unstructured":"Schilder AM (2010) Wegener\u2019s granulomatosis vasculitis and granuloma. Autoimmun Rev 9(7):483\u2013487","journal-title":"Autoimmun Rev"},{"issue":"4","key":"412_CR36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.autrev.2012.08.010","volume":"12","author":"M Trimarchi","year":"2013","unstructured":"Trimarchi M et al (2013) Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener\u2019s). Autoimmun Rev 12(4):501\u2013505","journal-title":"Autoimmun Rev"},{"issue":"3","key":"412_CR37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.5152\/eurjrheum.2015.0043","volume":"3","author":"C Pagnoux","year":"2016","unstructured":"Pagnoux C (2016) Updates in ANCA-associated vasculitis. Eur J Rheumatol 3(3):122\u2013133","journal-title":"Eur J Rheumatol"},{"key":"412_CR38","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ejim.2015.04.022","volume":"26","author":"M Groh","year":"2015","unstructured":"Groh M et al (2015) Eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med 26:545\u2013553","journal-title":"Eur J Intern Med"},{"key":"412_CR39","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1002\/art.21250","volume":"52","author":"RA Sinico","year":"2005","unstructured":"Sinico RA et al (2005) Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg\u2013Strauss syndrome. Arthr Rheum 52:2926\u20132935","journal-title":"Arthr Rheum"},{"key":"412_CR40","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","volume":"143","author":"R Sable-Fourtassou","year":"2005","unstructured":"Sable-Fourtassou R et al (2005) Antineutrophil cytoplasmic antibodies and the Churg\u2013Strauss syndrome. Ann Intern Med 143:632\u2013638","journal-title":"Ann Intern Med"},{"issue":"10","key":"412_CR41","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1681\/ASN.2010050477","volume":"21","author":"AE Berden","year":"2010","unstructured":"Berden AE et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21(10):1628\u20131636","journal-title":"J Am Soc Nephrol"},{"key":"412_CR42","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1093\/ndt\/gfr643","volume":"27","author":"DY Chang","year":"2012","unstructured":"Chang DY et al (2012) Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center. Nephrol Dial Transplant 27:2343\u20132349","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"412_CR43","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10157-012-0755-7","volume":"17","author":"E Muso","year":"2013","unstructured":"Muso E et al (2013) Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody associated glomerulonephritis in comparison with other Asian and European cohorts. Clin Exp Nephrol 17(5):659\u2013662","journal-title":"Clin Exp Nephrol"},{"issue":"2 Suppl 89","key":"412_CR44","first-page":"S56S63","volume":"33","author":"G Moroni","year":"2015","unstructured":"Moroni G et al (2015) Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopathological classification schema and review of the literature. Clin Exp Rheumatol 33(2 Suppl 89):S56\u2013S63","journal-title":"Clin Exp Rheumatol"},{"key":"412_CR45","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ndt\/gfu237","volume":"30","author":"A Tanna","year":"2015","unstructured":"Tanna A et al (2015) Long-term outcome of anti-neutrophil cytoplasm antibody-associated glomerulonephritis: evaluation of the international histological classification and other prognostic factors. Nephrol Dial Transplant 30:1185\u20131192","journal-title":"Nephrol Dial Transplant"},{"key":"412_CR46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/ndt\/gfs428","volume":"28","author":"M Hilhorst","year":"2013","unstructured":"Hilhorst M et al (2013) Improved outcome in anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis: a 30-year follow-up study. Nephrol Dial Transplant 28:373\u2013379","journal-title":"Nephrol Dial Transplant"},{"key":"412_CR47","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1093\/ndt\/gfu084","volume":"29","author":"LF Quintana","year":"2014","unstructured":"Quintana LF et al (2014) ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 29:1764\u20131769","journal-title":"Nephrol Dial Transplant"},{"key":"412_CR48","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1053\/j.ajkd.2013.08.025","volume":"63","author":"SL Ford","year":"2014","unstructured":"Ford SL et al (2014) Histopathologic and clinical predictors of kidney outcomes in ANCA-associated vasculitis. Am J Kidney Dis 63:227\u2013235","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"412_CR49","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2215\/CJN.04800516","volume":"11","author":"R Bjorneklett","year":"2016","unstructured":"Bjorneklett R et al (2016) Prognostic value of histologic classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol 11(12):2159\u20132167","journal-title":"Clin J Am Soc Nephrol"},{"key":"412_CR50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.humpath.2016.01.015","volume":"52","author":"F Diaz-Crespo","year":"2016","unstructured":"Diaz-Crespo F et al (2016) The predictive value of kidney biopsy in renal vasculitis: a multicenter cohort study. Hum Pathol 52:119\u2013127","journal-title":"Hum Pathol"},{"key":"412_CR51","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75:1583\u20131594","journal-title":"Ann Rheum Dis"},{"key":"412_CR52","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM197104292841703","volume":"284","author":"SN Novack","year":"1971","unstructured":"Novack SN, Pearson CM (1971) Cyclophosphamide therapy in Wegener\u2019s granulomatosis. N Engl J Med 284:938\u2013942","journal-title":"N Engl J Med"},{"key":"412_CR53","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","volume":"150","author":"K Groot De","year":"2009","unstructured":"De Groot K et al (2009) Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. Ann Intern Med 150:670\u2013680","journal-title":"Ann Intern Med"},{"key":"412_CR54","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/art.1780401213","volume":"40","author":"L Guillevin","year":"1997","unstructured":"Guillevin L et al (1997) A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener\u2019s granulomatosis. Arthr Rheum 40:2187\u20132198","journal-title":"Arthr Rheum"},{"key":"412_CR55","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/annrheumdis-2011-200477","volume":"71","author":"L Harper","year":"2012","unstructured":"Harper L et al (2012) Pulse versus daily oral cyclophosphamide for induction of remission in ANCA-associated vasculitis: long-term follow-up. Ann Rheum Dis 71:955\u2013960","journal-title":"Ann Rheum Dis"},{"key":"412_CR56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/art.22679","volume":"57","author":"P Cohen","year":"2007","unstructured":"Cohen P et al (2007) Churg\u2013Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthr Rheum 57:686\u2013693","journal-title":"Arthr Rheum"},{"key":"412_CR57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","volume":"363","author":"RB Jones","year":"2010","unstructured":"Jones RB et al (2010) Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363:211\u2013220","journal-title":"N Engl J Med"},{"key":"412_CR58","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","volume":"363","author":"JH Stone","year":"2010","unstructured":"Stone JH et al (2010) Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363:221\u2013232","journal-title":"N Engl J Med"},{"key":"412_CR59","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/annrheumdis-2014-206095","volume":"75","author":"AJ Mohammad","year":"2016","unstructured":"Mohammad AJ et al (2016) Rituximab for the treatment of eosinophilic granulomatosis with polyangiitis (Churg\u2013Strauss). Ann Rheum Dis 75:396\u2013401","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"412_CR60","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","volume":"18","author":"DR Jayne","year":"2007","unstructured":"Jayne DR et al (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. European Vasculitis Study Group. J Am Soc Nephrol 18(7):2180\u20132188","journal-title":"J Am Soc Nephrol"},{"key":"412_CR61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1745-6215-14-73","volume":"14","author":"M Walsh","year":"2013","unstructured":"Walsh M et al (2013) Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials 14:73","journal-title":"Trials"},{"key":"412_CR62","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","volume":"349","author":"D Jayne","year":"2003","unstructured":"Jayne D et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36\u201344","journal-title":"N Engl J Med"},{"key":"412_CR63","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","volume":"371","author":"L Guillevin","year":"2014","unstructured":"Guillevin L et al (2014) Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371:1771\u20131780","journal-title":"N Engl J Med"},{"key":"412_CR64","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1056\/NEJMoa0802311","volume":"359","author":"C Pagnoux","year":"2008","unstructured":"Pagnoux C et al (2008) Azathioprine or methotrexate maintenance for ANCA-associated vasculitis. N Engl J Med 359:2790\u20132803","journal-title":"N Engl J Med"},{"key":"412_CR65","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1001\/jama.2010.1658","volume":"304","author":"TF Hiemstra","year":"2010","unstructured":"Hiemstra TF et al (2010) Mycophenolate mofetil vs azathioprine for remission maintenance in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized controlled trial. JAMA 304:2381\u20132388","journal-title":"JAMA"},{"key":"412_CR66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/ard.2010.137778","volume":"70","author":"O Flossmann","year":"2010","unstructured":"Flossmann O et al (2010) Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70:488\u2013494","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"412_CR67","first-page":"60","volume":"30","author":"K Westman","year":"2015","unstructured":"Westman K, Flossmann O, Gregorini G (2015) The long-term outcomes of systemic vasculitis. Nephrol Dial Transplant 30(Suppl 1):60\u201366","journal-title":"Nephrol Dial Transplant"},{"key":"412_CR68","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2215\/CJN.13071211","volume":"7","author":"DY Chang","year":"2012","unstructured":"Chang DY et al (2012) Association of HLA genes with clinical outcomes of ANCA-associated vasculitis. Clin J Am Soc Nephrol 7:1293\u20131299","journal-title":"Clin J Am Soc Nephrol"},{"key":"412_CR69","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1523-1755.2003.00769.x","volume":"63","author":"MC Slot","year":"2003","unstructured":"Slot MC et al (2003) Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int 63:670\u2013677","journal-title":"Kidney Int"},{"key":"412_CR70","doi-asserted-by":"crossref","first-page":"621","DOI":"10.7326\/0003-4819-143-9-200511010-00005","volume":"143","author":"SL Hogan","year":"2005","unstructured":"Hogan SL et al (2005) Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med 143:621\u2013631","journal-title":"Ann Intern Med"},{"key":"412_CR71","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.autrev.2014.02.007","volume":"13","author":"G Moroni","year":"2014","unstructured":"Moroni G, Ponticelli C (2014) Rapidly progressive crescentic glomerulonephritis: early treatment is a must. Autoimmun Rev 13:723\u2013729","journal-title":"Autoimmun Rev"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-017-0412-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0412-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-017-0412-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:57Z","timestamp":1777564617000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/31\/2\/197\/8371255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,30]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["412"],"URL":"https:\/\/doi.org\/10.1007\/s40620-017-0412-z","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,30]]}}}